A bactericidal composition and method for inhibiting and controlling the growth of the capsulated, facultative bacterium, Klebsiella pneumoniae, are disclosed. The composition comprises an amount, effective for the intended purpose, of 2-bromo-2-nitropropane-l, 3-diol and an oxidizing biocide selected from the group consisting of hypochlorite, chlorine, and chlorine dioxide. The method comprises administering between about 0.1 to about 200 parts of this combined treatment (based on one million parts of the desired aqueous system) to the particular water containing system for which treatment is desired.

Patent
   4966775
Priority
Sep 12 1988
Filed
May 19 1989
Issued
Oct 30 1990
Expiry
Sep 12 2008
Assg.orig
Entity
Large
26
7
all paid
12. A bacterial inhibiting composition comprising a synergistic aqueous mixture of (a) 2-bromo-2-nitropropane-1, 3-diol ("bnpd") and (b) hypochlorite, wherein the weight ratio of said bnpd to said hypochlorite is from about 7:1 to 1:1.1.
1. A bacterial inhibiting composition comprising a synergistic aqueous mixture of (a) 2-bromo-2-nitropropane-1, 3-diol ("bnpd") and (b) an oxidizing biocide selected from the group consisting of hypochlorite, chlorine, and chlorine dioxide, wherein the weight ratio of said bnpd to said oxidizing biocide is from about 7:1 to 1:50.
14. A method for controlling the growth of Klebsiella pneumoniae bacteria in an aqueous system which comprises adding to said system from about 0.1 to 200 parts per weight of a composition per one million parts per weight of said aqueous system, said composition comprising syneristic a mixture of bnpd and hypochlorite, the weight ratio of said bnpd to said hypochlorite being from about 7:1 to 1:1.1.
5. A method for controlling the growth of Klebsiella pneumoniae bacteria in an aqueous system which comprises adding to said system from about 0.1 to 200 parts per weight of a composition per one million parts per weight of said aqueous system, said composition comprising syneristic a mixture of bnpd and an oxidizing biocide selected from the group consisting of hypochlorite, chlorine, and chlorine dioxide, the weight ratio of said bnpd to said oxidizing biocide being from about 7:1 to 1:50.
2. The composition as recited in claim 1 wherein said oxidizing biocide is hypochlorite.
3. The composition as recited in claim 1 wherein said oxidizing biocide is chlorine.
4. The composition as recited in claim 1 wherein said oxidizing biocide is chlorine dioxide.
6. The method as recited in claim 5 wherein said oxidizing biocide is hypochlorite.
7. The method as recited in claim 5 wherein said oxidizing biocide is chlorine.
8. The method as recited in claim 5 wherein said oxidizing biocide is chlorine dioxide.
9. The method as recited in claim 5 wherein said composition is added to said system in an amount of from about to about 5 to 50 parts per million of said aqueous system.
10. The method as recited in claim 5 wherein said aqueous system comprises a cooling water system.
11. The method as recited in claim 5 wherein said aqueous system comprises a pulping and papermaking system.
13. The composition as recited in claim 12 wherein the weight ratio of bnpd to hypochlorite is 7:1.
15. The method as recited in claim 14 wherein the weight ratio of bnpd:hypochlorite is about 7:1.
16. The method as recited in claim 14 wherein said composition is added to said system in an amount of from about to about 5 to 50 parts per million of said aqueous system.
17. The method as recited in claim 14 wherein said aqueous system comprises a cooling water system.
18. The method as recited in claim 14 wherein said aqueous system comprises a pulping and papermaking system.

This is a continuation-in-part of application Ser. No. 07/242,837 filed Sept. 12, 1988, now U.S. Pat. No. 4,855,296.

The formation of slimes by microorganisms is a problem that is encountered in many aqueous systems For example, the problem is not only found in natural waters such as lagoons, lakes, ponds, etc., and confined waters as in pools, but also in such industrial systems as cooling water systems, air washer systems and pulp and paper mill systems. All possess conditions which are conducive to the growth and reproduction of slime-forming microorganisms. In both once-through and recirculating cooling systems, for example, which employ large quantities of water as a cooling medium, the formation of slime by microorganisms is an extensive and constant problem.

Airborne organisms are readily entrained in the water from cooling towers and find this warm medium an ideal environment for growth and multiplication. Aerobic and heliotropic organisms fluorish on the tower proper while other organisms colonize and grow in such areas as the tower sump and the piping and passages of the cooling system. The slime formation not only aids in the deterioration of the tower structure in the case of wooden towers, but also promotes corrosion when it deposits on metal surfaces. Slime carried through the cooling system plugs and fouls lines, valves, strainers, etc., and deposits on heat exchange surfaces. In the latter case, the impedance of heat transfer can greatly reduce the efficiency of the cooling system.

In pulp and paper mill systems, slime formed by microorganisms is commonly encountered and causes fouling, plugging, or corrosion of the system. The slime also becomes entrained in the paper produced to cause breakouts on the paper machines, which results in work stoppages and the loss of production time. The slime is also responsible for unsightly blemishes in the final product, which result in rejects and wasted output.

The previously discussed problems have resulted in the extensive utilization of biocides in cooling water and pulp and paper mill systems. Materials which have employed widespread use in such applications include chlorine, chlorinated phenols, organo-bromines, and various organo-sulfur compounds. All of these compounds are generally useful for this purpose but each is attended by a variety of impediments. For example, chlorination is limited both by its specific toxicity for slime-forming organisms at economic levels and by the tendency of chlorine to react, which results in the expenditure of the chlorine before its full biocidal function is achieved. Other biocides are attended by odor problems and hazards in respect to storage, use or handling which limit their utility. To date, no one compound or type of compound has achieved a clearly established predominance in respect to the applications discussed. Likewise, lagoons, ponds, lakes, and even pools, either used for pleasure purposes or used for industrial purposes for the disposal and storage of industrial wastes, become, during the warm weather, beseiged by slime due to microorganisms growth and reproduction. In the case of the recreational areas the problem of infection is obvious. In the case of industrial storage or disposal of industrial materials, the microorganisms cause additional problems which must be eliminated prior to the material's use or disposal of the waste.

Naturally, economy is a major consideration in respect to all of these biocides. Such economic considerations attach to both the cost of the biocide and the expense of its application. The cost performance index of any biocide is derived from the basic cost of the material, its effectiveness per unit of weight, the duration of its biocidal or biostatic effect in the system treated, and the ease and frequency of its addition to the system treated. To date, none of the commercially available biocides has exhibited a prolonged biocidal effect. Instead, their effectiveness is rapidly reduced as the result of exposure to physical conditions such as temperature, association with ingredients contained by the system toward which they exhibit an affinity or substantivity, etc., with a resultant restriction or elimination of their biocidal effectiveness, or by dilution.

As a consequence, the use of such biocides involves their continuous or frequent addition to systems to be treated and their addition to multiple points or zones in the systems to be treated. Accordingly, the cost of the biocide and the labor cost of such means of applying it are considerable. In other instances, the difficulty of access to the zone in which slime formation is experienced precludes the effective use of a biocide. For example, if in a particular system there is no access to an area at which slime formation occurs the biocide can only be applied at a point which is upstream in the flow system. However, the physical or chemical conditions, e.g., chemical reactivity, thermal degradation, etc., which exist between the point at which the biocide may be added to the system and the point at which its biocidal effect is desired render the effective use of a biocide impossible.

Similarly, in a system experiencing relatively slow flow, such as a paper mill, if a biocide is added at the beginning of the system, its biocidal effect may be completely dissipated before it has reached all of the points at which this effect is desired or required. As a consequence, the biocide must be added at multiple points, and even then a diminishing biocidal effect will be experienced between one point of addition to the system and the next point downstream at which the biocides may be added. In addition to the increased cost of utilizing and maintaining multiple feed points, gross ineconomies in respect to the cost of the biocide are experienced. Specifically, at each point of addition, an excess of the biocide is added to the system in order to compensate for that portion of the biocide which will be expended in reacting with other constituents present in the system or experience physical changes which impair its biocidal activity.

Most industrial disinfection is done by adding gaseous chlorine to water. In water, gaseous chlorine hydrolyzes to form hypochlorous acid and hypochlorite ions, the predominant species depending on the pH of the water. Sodium hypochlorite can also be used instead of gaseous chlorine, as can other hypochlorite salts. All hypochlorite salts dissolve in water to form hypochlorite ions and hypochlorons acid, again the predominant species depending on the pH of the water. As used herein the term "chlorine" refers to the presence of hypochlorous acid and/or hypochlorite ions in water regardless of the physical form the chlorine has prior to dissolution in the water.

The biocidal compositions of the present invention comprise, as active ingredients, (1) 2-bromo-2-nitropropane-1, 3-diol ("BNPD") and (2) an oxidizing biocide, such as chlorine.

Other exemplary oxidizing biocides which the inventors believe will exhibit synergism in the proper combinations with BNPD are chlorine dioxide, bromine, ozone, peroxides and peracetic acid.

BNPD is sold by the Boots Company Ltd., Nottingham, England as an industrial water treatment antibacterial agent. Of interest regarding the uses of BNPD are Chemical Abstract, volume 95 (1981) 199029f, disclosing the use of a compositions comprising 4-5-dichloro-1, 2-dithiol-3-one and BNP, and Bryce, et al. Chemical Abstracts volume 89 (1978) 117510v, reviewing references describing the microbial chemical analystical properties, and, formulation of Bronopol (a tradename of Boots for BNPD). Neither of the abstracts discloses the compositions of the present inventions nor the utilization of such a composition to inhibit Klebsiella pneumoniae growth.

BNPD has been used in conjunction with other biocidal compounds as described in the following U.S. patents of common assignment and inventorship herewith: U.S. Pat. No. 4,725,587 to Whitekettle and Donofrio, U.S. Pat. No. 4,725,623 to Whitekettle and Donofrio, U.S. Pat. No. 4,725,624 to Whitekettle and Donofrio, U.S. Pat. No. 4,732,905 to Donofrio and Whitekettle, U.S. Pat. No. 4,732,911 to Whitekettle and Donofrio, U.S. Pat. No. 4,732,913 to Donofrio and Whitekettle and U.S. Pat. No. 4,753,961 to Donofrio and Whitekettle.

BNPD has also been used in conjunction with other biocidal compounds in the following copending U.S. patent applications of common assignment and inventorship herewith, Ser. Nos.: 07/242,840; 07/242,831; 07/242,841; 07/243,007; 07/242,846.

Chlorine is a known oxidizing biocidal composition commercially available from Jones Chemical Company, Olin Corporation, and Pennwalt Corporation. Chlorine is well known and documented for its industrial disinfection properties. See, for example, Moore, Edward W., "Fundamentals of Chlorination of Sewage and Waste", Water and Sewage Works, Vol. 98 No. 3, (March 1951); Baker, R. J., "Chlorination of Industrial Water Supplies", 9th Annual Liberty Bell Corrosion Course (1971). Chlorine, chlorine dioxide, ozone, peroxides and peracetic acid are examples of oxidizing biocides which should exhibit synergism in the proper combination with BNPD.

Although BNPD, chlorine, chlorine dioxide, ozone, peroxides, and peracetic acid are known biocidal compounds; the synergistic effect obtained by combining BNPD and an oxidizing biocide selected from the group consisting of chlorine and chlorine dioxide has not been previously disclosed.

Surprisingly, the present inventors have found that mixtures of 2-bromo-2-nitropropane-1, 3-diol ("BNPD") and an oxidizing biocide are especially efficacious in controlling the growth of bacterial microbes, specifically the Klebsiella pneumoniae species. Specifically, the inventors found that mixtures of BNPD and hypochlorite are especially efficacious in controlling the growth of bacterial microbes, specifically Klebsiella pneumoniae. Based on these findings, it is postulated that mixtures of BNPD and strong oxidizers, particularly hypohalous acids, such as hypochlorous, hypobromous and hypoiodic acids, and their salts as well as mixtures of BNPD and chlorine dioxide, will be equally efficacious.

The Klebsiella pneumoniae species is a member of the capsulated, facultative class of bacteria and is generally present in air, water and soil. These bacteria continually contaminate open cooling systems and pulping and papermaking systems and are among the most common slime formers. The slime may be viewed as being a mass of agglomerated cells stuck together by the cementing action of the gelatinous polysaccharide or proteinaceous secretions around each cell. The slimy mass entraps other debris, restricts water flow and heat transfer, and may serve as a site for corrosion.

The fact that the Klebsiella species used in the tests is a facultative species is important as, by definition, such bacteria may thrive under either aerobic or anaerobic conditions. Accordingly, by reason of demonstrated efficacy in the growth inhibition of this particular species, one can expect similar growth inhibition attributes when other aerobic or anaerobic bacterial species are encountered. It is also expected that these compositions will exhibit similar growth inhibition attributes when fungi and algae species are encountered.

Hypochlorite/hypochlorous acid is available from The Chlorox Company, Oakland, Calif. under the tradename "Clorox". It is 5.25% pure. It is usually available as sodium hypochlorite. It is readily soluble in water.

Gaseous chlorine is available from Jones Chemical Company. It is 98-100% pure. Gaseous chlorine is usually available as chlorine gas in cylinders. It is readily soluble in water.

Chlorine dioxide is usually generated on site from either gaseous chlorine or sodium chlorate using a chlorine dioxide generator available from Lamb-Weston, Portland, Oreg. Once generated it is usually available as 0.05-1.0% aqueous solution. It is a readily soluble gas in water.

As noted above, BNPD is available from The Boots Company, Ltd. and is sold under the trademarks "Myacide AS" or "Bronopol" it is a white, free flowing, crystalline solid that is readily soluble in cold water. The product is from about 95-100% pure.

In accordance with the present invention, the combined BNPD and oxidizing biocide treatment may be added to the desired aqueous system in need of biocidal treatment, in an amount of from about 0.1 to about 200 parts of the combined treatment to one million parts (by weight) of the aqueous medium. Preferably, about 5 to about 50 parts of the combined treatment per one million parts (by weight) of the aqueous medium is added.

The combined treatment is added, for example, to cooling water systems, paper and pulp mill systems, pools, ponds, lagoons, lakes, etc., to control the formation of bacterial microorganisms, which may be contained by, or which may become entrained in, the system to be treated. It has been found that the BNPD and oxidizing biocide compositions and methods of utilization of the treatment are efficacious in controlling the facultative bacterium, Klebsiella pneumoniae, which may populate these systems. It is thought that the combined treatment composition and method of the present invention will also be efficacious in inhibiting and controlling all types of aerobic and anaerobic bacteria.

Surprisingly, it has been found that when the BNPD and oxidizing biocide ingredients are mixed, in certain instances, the resulting mixtures possess a higher degree of bactericidal activity than that of the individual ingredients comprising the mixture. Accordingly, it is possible to produce a highly efficacious bactericide. Because of the enhanced activity of the mixture, the total quantity of the bacterial treatment may be reduced. In addition, the high degree of bactericidal effectiveness which is provided by each of the ingredients may be exploited without use of higher concentrations of each.

The following experimental data were developed. It is to be remembered that the following examples are to be regarded solely as being illustrative, and not as restricting the scope of the invention.

BNPD and hypochlorite were added in varying ratios and over a wide range of concentrations to a liquid nutrient medium which was subsequently inoculated with a standard volume of a suspension of the facultative bacterium Klebsiella pneumoniae. Growth was measured by determining the amount of radioactivity accumulated by the cells when 14 C-glucose was added as the sole source of carbon in the nutrient medium. The effect of the biocide chemicals, alone and in combination, is to reduce the rate and amount of 14 C incorporation into the cells during incubation, as compared to controls not treated with the chemicals. Additions of the biocides, alone and in varying combinations and concentrations, were made according to the accepted "checkerboard" technique described by M. T. Kelley and J. M. Matsen, Antimicrobial Agents and Chemotherapy. 9: 440 (1976). Following a two hour incubation, the amount of radioactivity incorporated in the cells was determined by counting (14 C liquid scintillation procedures) for all treated and untreated samples. The percent reduction of each treated sample was calculated from the relationship: ##EQU1##

Plotting the % reduction of 14 C level against the concentration of each biocide acting alone results in a dose-response curve, from which the biocide dose necessary to achieve any given % reduction can be interpolated.

Synergism was determined by the method of calculation described by F. C. Kull, P. C. Eisman, H. D. Sylwestrowicz and R. L. Mayer, Applied Microbiology 9,538 (1961) using the relationship. ##EQU2## where: Qa =quantity of compound A, acting alone, producing an end point

Qb =quantity of compound B, acting alone, producing an end point

QA =quantity of compound A in mixture, producing an end point

QB =quantity of compound B in mixture, producing an end point

The end point used in the calculations is the % reduction caused by each mixture of A and B. QA and QB are the individual concentrations in the A/B mixture causing a given % reduction. Qa and Qb are determined by interpolation from the respective dose-response curves of A and B as those concentrations of A and B acting alone which produce the same % reduction as each specific mixture produced.

Dose-response curves for each active acting alone were determined by linear regression analysis of the dose-response data. Data were fitted to a curve represented by the equation shown with each data set. After linearizing the data, the contributions of each biocide component in the biocide mixtures to the inhibition of radioisotope uptake were determined by interpolation with the dose-response curve of the respective biocide. If, for example, quantities of QA plus QB are sufficient to give a 50% reduction in 14 C content, Qa and Qb are those quantities of A or B acting alone, respectively, found to give 50% reduction in 14 C content. A synergism index (SI) is calculated for each combination of A and B.

Where the SI is <1, synergism exists. Where the SI=1, additivity exists. Where SI>1, antagonism exists.

The data in the following tables comes from treating Klebsiella pneumoniae, a common nuisance bacterial type found in industrial cooling waters and in pulping and paper making systems, with varying ratios and concentrations of BNPD and hydantoin. Shown for each combination is the % reduction of 14 C content (% I), the calculated SI, and the weight ratio of BNPD and hypochlorite.

TABLE I
______________________________________
BNPD vs. Hypochlorite
ppm ppm ratio
BNPD hypochlorite**
BNPD:hypochlorite
% I SI
______________________________________
0 175 0:100 89
0 125 0:100 0
0 87.5 0:100 0
0 62.5 0:100 0
0 31.25 0:100 0
0 15.6 0:100 0
80 0 100:0 95
40 0 100:0 89
20 0 100:0 63
10 0 100:0 27
5 0 100:0 11
2.5 0 100:0 3
80 175 1:2.2 98 1.27
80 125 1:1.6 97 1.89
80 87.5 1:1.1 97 1.68
80 62.5 1.3:1 94 1.66
80 31.25 2.6:1 96 1.41
80 15.6 5.1:1 96 1.32
40 175 1:4.4 97 1.57
40 125 1:3.1 95 1.34
40 87.5 1:2.2 95 1.13
40 62.5 1:1.6 90 1.10
40 31.25 1.3:1 90 0.92*
40 15.6 2.6:1 91 0.82*
20 175 1:8.8 95 1.30
20 125 1:6.3 92 1.06
20 87.5 1:4.4 92 0.85*
20 62.5 1:3.1 82 0.84*
20 31.25 1:1.6 75 0.79*
20 15.6 1.3:1 74 0.72*
10 175 1:17.5 94 1.15
10 125 1:12.5 88 0.92*
10 87.5 1:8.8 88 0.70*
10 62.5 1:6.3 43 1.25
10 31.25 1:3.1 27 1.65
10 15.6 1:1.6 46 0.87*
5 175 1:35 93 1.07
5 125 1:25 78 0.87*
5 87.5 1:17.5 82 0.63*
5 62.5 1:12.5 0
5 31.25 1:6.3 23 1.06
5 15.6 1:3.1 37 0.61*
2.5 175 1:70 92 1.03
2.5 125 1:50 44 1.04
2.5 87.5 1:35 45 0.78*
2.5 62.5 1:25 0
2.5 31.25 1:12.5 22 0.64*
2.5 15.6 1:6.2 19 0.56*
______________________________________
TABLE II
______________________________________
BNPD vs. Hypochlorite
ppm ppm ratio
BNPD hypochlorite**
BNPD:hypochlorite
% I SI
______________________________________
0 175 0:100 88
0 125 0:100 26
0 87.5 0:100 0
0 62.5 0:100 0
0 31.25 0:100 0
0 15.6 0:100 0
80 0 100:0 95
40 0 100:0 88
20 0 100:0 64
10 0 100:0 26
5 0 100:0 10
2.5 0 100:0 1
80 175 1:2.2 99 2.06
80 125 1:1.6 99 1.79
80 87.5 1:1.1 99 1.59
80 62.5 1.3:1 98 1.49
80 31.25 2.6:1 95 1.44
80 15.6 5.1:1 96 1.32
40 175 1:4.4 99 1.49
40 125 1:3.1 99 1.23
40 87.5 1:2.2 97 1.07
40 62.5 1:1.6 91 1.07
40 31.25 1.3:1 91 0.90*
40 15.6 2.6:1 91 0.81*
20 175 1:8.8 98 1.23
20 125 1:6.3 97 0.97
20 87.5 1:4.4 93 0.82*
20 62.5 1:3.1 . 80 0.88*
20 31.25 1:1.6 65 1.00
20 15.6 1.3:1 72 0.74*
10 175 1:17.5 95 1.11
10 125 1:12.5 94 0.85*
10 87.5 1:8.8 89 0.68*
10 62.5 1:6.3 14 2.59
10 31.25 1:3.1 45 1.00
10 15.6 1:1.6 46 0.83*
5 175 1:35 95 1.03
5 125 1:25 91 0.79*
5 87.5 1:17.5 69 0.73*
5 62.5 1:12.5 0
5 31.25 1:6.3 29 0.88*
5 15.6 1:3.1 33 0.68*
2.5 175 1:70 93 1.00
2.5 125 1:50 89 0.75*
2.5 87.5 1:35 21 1.19
2.5 62.5 1:25 0
2.5 31.25 1:12.5 28 0.59*
2.5 15.6 1:6.2 30 0.43*
______________________________________

Asterisks in the SI column indicate synergistic combinations in accordance with the Kull method supra. The double asterisk indicates that the tested hypochlorite was about 2.2% active ingredients.

In Tables I and II, differences seen between the replicates are due to normal experimental variance.

In accordance with Tables I-II supra., unexpected results occurred more frequently within the product ratios of BNPD to hypochlorite of from about 2.6:1 to 1:50.

At present, it is preferred that the commercial product embodying the invention comprise a product ratio of about 1:6.2 BNPD to hypochlorite.

Since the tested BNPD was about 100% active biocidal ingredient, and the tested hypochlorite was about 2.2% active biocidal ingredient, the unexpected results above occurred more frequently within the weight ratio range of 120:1 to 1:1.1 on a 100% actives basis of BNPD:hypochlorite. The preferred weight ratio on a 100% actives basis is 7:1 BNPD:hypochlorite.

Based upon the chemical similarities of hypochlorous acid/hypochlorite, chlorine and chlorine dioxide, it is expected that chlorine will exhibit unexpected synergistic activity in combination with BNPD in the following weight ratio based upon 100% actives 120:1 to 1:1.1. It is also expected that chlorine dioxide will exhibit unexpected synergistic activity in combination with BNPD in the following weight ratio (based on 100% actives) 150:1 to 1:100.

While this invention has been described with respect to particular embodiments thereof, it is apparent that numerous other forms and modifications of this invention will be obvious to those skilled in the art. The appended claims and this invention generally should be construed to cover all such obvious forms and modifications which are within the true spirit and scope of the present invention.

Donofrio, Deborah K., Whitekettle, Wilson K.

Patent Priority Assignee Title
5093357, Mar 25 1991 Betz Laboratories, Inc. Biocidal compositions and use thereof containing a synergistic mixture of diiodomethyl-p-tolylsulfone and 3,4-dichloro-1,2-dithiol-3-one
5494588, Aug 05 1993 Ecolab USA Inc Method and composition for inhibiting growth of microorganisms including peracetic acid and a second organic biocide
5562835, Nov 30 1993 Ashland Licensing and Intellectual Property LLC Process for reducing the population of bacteria in contaminated aqueous systems
5658467, Aug 05 1993 Ecolab USA Inc Method and composition for inhibiting growth of microorganisms including peracetic acid and a non-oxidizing biocide
5707739, Jun 05 1995 Southwest Research Institute Powdered biocidal compositions
5736057, Jul 29 1993 Promox S.R.L. Process for the purifying of waters for human consumption
5820763, Mar 20 1997 Kurita Water Industries, Ltd. Method for inhibiting corrosion in water systems
5888428, Oct 30 1992 BIOLAB SERVICES INC Methods for generating residual disinfectants during the ozonization of water
5888528, May 19 1997 MICROACTIVE CORP Sustained release biocidal powders
5965264, Sep 18 1996 BARRIERSAFE SOLUTIONS INTERNATIONAL, INC Powders providing controlled sustained release of a gas
5965617, Feb 02 1998 Angus Chemical Company Method and composition for controlling microbial growth using bromontrostyene and peracetic acid
5980758, Aug 05 1993 Ecolab USA Inc Method and composition for inhibiting growth of microorganisms including peracetic acid and a non-oxidizing biocide
6046243, Feb 12 1993 MICROACTIVE CORP Compositions for sustained release of a gas
6277408, Feb 09 1998 MICROACTIVE CORP Silicate-containing powders providing controlled, sustained gas release
6284144, Jul 30 1998 Argad-Eyal Water Treatment Industries Inc. Water treatment
6290830, Oct 29 1999 PPG Industries Ohio, Inc Electrodepositable coatings, aqueous rinsing systems for treating electrocoated substrates and processes related thereto
6605304, Feb 09 1998 MICROACTIVE CORP Silicate-containing powders providing controlled, sustained gas release
6619051, Jul 12 2002 Ecolab USA Inc Integrated cleaning and sanitizing system and method for ice machines
6620380, Sep 14 2001 Ecolab USA Inc Method, device and composition for the sustained release of an antimicrobial gas
7008545, Aug 22 2002 SOLENIS TECHNOLOGIES, L P Synergistic biocidal mixtures
7285255, Dec 10 2002 Ecolab USA Inc Deodorizing and sanitizing employing a wicking device
7670551, Dec 10 2002 Ecolab Inc. Deodorizing and sanitizing employing a wicking device
7718715, Jun 10 2004 S.C. Johnson & Son, Inc. pH-modified latex comprising a synergistic combination of biocides
8765652, Mar 05 2004 Gen-Probe Incorporated Method of making a formulation for deactivating nucleic acids
8986606, May 23 2008 KEMIRA OYJ Chemistry for effective microbe control with reduced gas phase corrosiveness in pulp and paper processing systems
9371556, Mar 05 2004 Hologic, Inc; Biolucent, LLC; Cytyc Corporation; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC ; Third Wave Technologies, INC; Gen-Probe Incorporated Solutions, methods and kits for deactivating nucleic acids
Patent Priority Assignee Title
4725587, Apr 13 1987 Hercules Incorporated Biocidal compositions and use thereof containing a synergistic mixture of 2-bromo-2-nitropropane-1,3-diol and tri-n-butyl tetradecyl phosphonium chloride
4725623, Feb 25 1987 Hercules Incorporated Biocidal compositions and use thereof containing a synergistic mixture of 2-bromo-2-nitropropane-1,3-diol and n-dodecylguanidine
4725624, Mar 13 1987 BETZDEARBORN INC Biocidal compositions and use thereof containing a synergistic mixture of 2-bromo-2-nitropropane-1,3-diol and n-alkyl dimethyl benzyl ammonium chloride
4732905, Mar 13 1987 Betz Laboratories, Inc. Biocidal compositions and use thereof containing a synergistic mixture of 2-bromo-2-nitropropane-1,3-diol and a mixture of 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one
4732911, Mar 13 1987 Betz Laboratories, Inc. Biocidal compositions and use thereof containing a synergistic mixture of 2-bromo-2-nitropropane-1,3-diol and bis (tri n-butyl tin) oxide
4732913, Feb 25 1987 Betz Laboratories, Inc. Biocidal compositions and use thereof containing a synergistic mixture of 2-bromo-2-nitropropane-1,3-diol and 2,2-dibromo-3-nitrilopropionamide
4753961, Sep 03 1987 Betz Laboratories, Inc. Biocidal compositions and use thereof containing a synergistic mixture of 2-bromo-2-nitropropane-1,3-diol and tetradecyl dimethyl sulfonium methosulfate
////////////////////////////////////////////////////////////////
Executed onAssignorAssigneeConveyanceFrameReelDoc
May 12 1989WHITEKETTLE, WILSON K BETZ LABORATORIES, INC ASSIGNMENT OF ASSIGNORS INTEREST 0051200992 pdf
May 12 1989DONOFRIO, DEBORAH K BETZ LABORATORIES, INC ASSIGNMENT OF ASSIGNORS INTEREST 0051200992 pdf
May 19 1989Betz Laboratories(assignment on the face of the patent)
Jun 21 1996BETZ LABORATORIES, INC BETZDEARBORN INC CHANGE OF NAME SEE DOCUMENT FOR DETAILS 0087830712 pdf
Nov 14 2000EAST BAY REALTY SERVICES, INC , A DELAWARE CORPORATIONBANK OF AMERICA, N A , AS COLLATERAL AGENTNOTICE OF GRANT OF SECURITY INTEREST0115900943 pdf
Nov 14 2000COVINGTON HOLDINGS, INC , A DELAWARE CORPORATIONBANK OF AMERICA, N A , AS COLLATERAL AGENTNOTICE OF GRANT OF SECURITY INTEREST0115900943 pdf
Nov 14 2000CHEMICAL TECHNOLOGIES INDIA, LTD , A DELAWARE CORPORATIONBANK OF AMERICA, N A , AS COLLATERAL AGENTNOTICE OF GRANT OF SECURITY INTEREST0115900943 pdf
Nov 14 2000BL CHEMICALS INC , A DELAWARE CORPORATIONBANK OF AMERICA, N A , AS COLLATERAL AGENTNOTICE OF GRANT OF SECURITY INTEREST0115900943 pdf
Nov 14 2000BETZDEARBORN CHINA, LTD , A DELAWARE CORPORATIONBANK OF AMERICA, N A , AS COLLATERAL AGENTNOTICE OF GRANT OF SECURITY INTEREST0115900943 pdf
Nov 14 2000FIBERVISIONS, L P , A DELAWARE LIMITED PARTNERSHIPBANK OF AMERICA, N A , AS COLLATERAL AGENTNOTICE OF GRANT OF SECURITY INTEREST0115900943 pdf
Nov 14 2000HERCULES CHEMICAL CORPORATION, A DELAWARE CORPORATIONBANK OF AMERICA, N A , AS COLLATERAL AGENTNOTICE OF GRANT OF SECURITY INTEREST0115900943 pdf
Nov 14 2000HERCULES COUNTRY CLUB, INC , A DELAWARE CORPORATIONBANK OF AMERICA, N A , AS COLLATERAL AGENTNOTICE OF GRANT OF SECURITY INTEREST0115900943 pdf
Nov 14 2000HERCULES EURO HOLDINGS, LLC, A DELAWARE LIMITED LIABILITY COMPANYBANK OF AMERICA, N A , AS COLLATERAL AGENTNOTICE OF GRANT OF SECURITY INTEREST0115900943 pdf
Nov 14 2000HERCULES INTERNATIONAL LIMITED, L L C , A DELAWARE LIMITED LIABILITY COMPANYBANK OF AMERICA, N A , AS COLLATERAL AGENTNOTICE OF GRANT OF SECURITY INTEREST0115900943 pdf
Nov 14 2000HERCULES INVESTMENTS, LLC, A DELAWARE LIMITED LIABILITY COMPANYBANK OF AMERICA, N A , AS COLLATERAL AGENTNOTICE OF GRANT OF SECURITY INTEREST0115900943 pdf
Nov 14 2000HISPAN CORPORATION, A DELAWARE CORPORATIONBANK OF AMERICA, N A , AS COLLATERAL AGENTNOTICE OF GRANT OF SECURITY INTEREST0115900943 pdf
Nov 14 2000ATHENS HOLDINGS, INC , A DELAWARE CORPORATIONBANK OF AMERICA, N A , AS COLLATERAL AGENTNOTICE OF GRANT OF SECURITY INTEREST0115900943 pdf
Nov 14 2000BETZDEARBORN INTERNATIONAL, INC , A PENNSYLVANIA CORPORATIONBANK OF AMERICA, N A , AS COLLATERAL AGENTNOTICE OF GRANT OF SECURITY INTEREST0115900943 pdf
Nov 14 2000HERCULES SHARED SERVICES CORPORATION, A DELAWARE CORPORATIONBANK OF AMERICA, N A , AS COLLATERAL AGENTNOTICE OF GRANT OF SECURITY INTEREST0115900943 pdf
Nov 14 2000HERCULES INCORPORATED, A DELAWARE CORPORATIONBANK OF AMERICA, N A , AS COLLATERAL AGENTNOTICE OF GRANT OF SECURITY INTEREST0115900943 pdf
Nov 14 2000HERCULES CREDIT, INC , A DELAWARE CORPORATIONBANK OF AMERICA, N A , AS COLLATERAL AGENTNOTICE OF GRANT OF SECURITY INTEREST0115900943 pdf
Nov 14 2000HERCULES FLAVOR, INC , A DELAWARE CORPORATIONBANK OF AMERICA, N A , AS COLLATERAL AGENTNOTICE OF GRANT OF SECURITY INTEREST0115900943 pdf
Nov 14 2000WSP, INC , A DELAWARE CORPORATIONBANK OF AMERICA, N A , AS COLLATERAL AGENTNOTICE OF GRANT OF SECURITY INTEREST0115900943 pdf
Nov 14 2000AQUALON COMPANY, A DELAWARE PARTNERSHIPBANK OF AMERICA, N A , AS COLLATERAL AGENTNOTICE OF GRANT OF SECURITY INTEREST0115900943 pdf
Nov 14 2000HERCULES FINANCE COMPANY, A DELAWARE PARTNERSHIPBANK OF AMERICA, N A , AS COLLATERAL AGENTNOTICE OF GRANT OF SECURITY INTEREST0115900943 pdf
Nov 14 2000FIBERVISIONS, L L C , A DELAWARE LIMITED LIABILITY COMPANYBANK OF AMERICA, N A , AS COLLATERAL AGENTNOTICE OF GRANT OF SECURITY INTEREST0115900943 pdf
Nov 14 2000FIBERVISIONS INCORPORATED, A DELAWARE CORPORATIONBANK OF AMERICA, N A , AS COLLATERAL AGENTNOTICE OF GRANT OF SECURITY INTEREST0115900943 pdf
Nov 14 2000FIBERVISIONS PRODUCTS, INC , A GEORGIA CORPORATIONBANK OF AMERICA, N A , AS COLLATERAL AGENTNOTICE OF GRANT OF SECURITY INTEREST0115900943 pdf
Nov 14 2000BLI HOLDINGS CORP , A DELAWARE CORPORATIONBANK OF AMERICA, N A , AS COLLATERAL AGENTNOTICE OF GRANT OF SECURITY INTEREST0115900943 pdf
Nov 14 2000BL TECHNOLOGIES, INC , A DELAWARE CORPORATIONBANK OF AMERICA, N A , AS COLLATERAL AGENTNOTICE OF GRANT OF SECURITY INTEREST0115900943 pdf
Nov 14 2000D R C LTD , A DELAWARE CORPORATIONBANK OF AMERICA, N A , AS COLLATERAL AGENTNOTICE OF GRANT OF SECURITY INTEREST0115900943 pdf
Nov 14 2000BETZDEARBORN EUROPE, INC , A PENNSYLVANIA CORPORATIONBANK OF AMERICA, N A , AS COLLATERAL AGENTNOTICE OF GRANT OF SECURITY INTEREST0115900943 pdf
Nov 14 2000BETZDEARBORN INC , A PENNSYLVANIA CORPORATIONBANK OF AMERICA, N A , AS COLLATERAL AGENTNOTICE OF GRANT OF SECURITY INTEREST0115900943 pdf
Nov 14 2000HERCULES INTERNATIONAL LIMITED, A DELAWARE CORPORATIONBANK OF AMERICA, N A , AS COLLATERAL AGENTNOTICE OF GRANT OF SECURITY INTEREST0115900943 pdf
Dec 19 2002BANK OF AMERICA, N A , AS COLLATERAL AGENTATHENS HOLDINGS, INC RELEASE OF SECURITY INTEREST0136690635 pdf
Dec 19 2002BANK OF AMERICA, N A , AS COLLATERAL AGENTBETZDEARBORN CHINA, LTD RELEASE OF SECURITY INTEREST0136690635 pdf
Dec 19 2002BANK OF AMERICA, N A , AS COLLATERAL AGENTBL CHEMICALS INC RELEASE OF SECURITY INTEREST0136690635 pdf
Dec 19 2002BANK OF AMERICA, N A , AS COLLATERAL AGENTCHEMICAL TECHNOLOGIES INDIA, LTD RELEASE OF SECURITY INTEREST0136690635 pdf
Dec 19 2002BANK OF AMERICA, N A , AS COLLATERAL AGENTCOVINGTON HOLDINGS, INC RELEASE OF SECURITY INTEREST0136690635 pdf
Dec 19 2002BANK OF AMERICA, N A , AS COLLATERAL AGENTEAST BAY REALTY SERVICES, INC RELEASE OF SECURITY INTEREST0136690635 pdf
Dec 19 2002BANK OF AMERICA, N A , AS COLLATERAL AGENTFIBERVISIONS, L P RELEASE OF SECURITY INTEREST0136690635 pdf
Dec 19 2002BANK OF AMERICA, N A , AS COLLATERAL AGENTHERCULES CHEMICAL CORPORATIONRELEASE OF SECURITY INTEREST0136690635 pdf
Dec 19 2002BANK OF AMERICA, N A , AS COLLATERAL AGENTHERCULES COUNTRY CLUB, INC RELEASE OF SECURITY INTEREST0136690635 pdf
Dec 19 2002BANK OF AMERICA, N A , AS COLLATERAL AGENTHERCULES EURO HOLDINGS, LLCRELEASE OF SECURITY INTEREST0136690635 pdf
Dec 19 2002BANK OF AMERICA, N A , AS COLLATERAL AGENTHERCULES INTERNATIONAL LIMITED, L L C RELEASE OF SECURITY INTEREST0136690635 pdf
Dec 19 2002BANK OF AMERICA, N A , AS COLLATERAL AGENTHISPAN CORPORATIONRELEASE OF SECURITY INTEREST0136690635 pdf
Dec 19 2002BANK OF AMERICA, N A , AS COLLATERAL AGENTBETZBEARBORN INTERNATIONAL, INC RELEASE OF SECURITY INTEREST0136690635 pdf
Dec 19 2002BANK OF AMERICA, N A , AS COLLATERAL AGENTHERCULES INVESTMENTS, LLCRELEASE OF SECURITY INTEREST0136690635 pdf
Dec 19 2002BANK OF AMERICA, N A , AS COLLATERAL AGENTHERCULES SHARED SERVICES CORPORATIONRELEASE OF SECURITY INTEREST0136690635 pdf
Dec 19 2002BANK OF AMERICA, N A , AS COLLATERAL AGENTHERCULES CREDIT, INC RELEASE OF SECURITY INTEREST0136690635 pdf
Dec 19 2002BANK OF AMERICA, N A , AS COLLATERAL AGENTHERCULES FLAVOR, INC RELEASE OF SECURITY INTEREST0136690635 pdf
Dec 19 2002BANK OF AMERICA, N A , AS COLLATERAL AGENTWSP, INC RELEASE OF SECURITY INTEREST0136690635 pdf
Dec 19 2002BANK OF AMERICA, N A , AS COLLATERAL AGENTAqualon CompanyRELEASE OF SECURITY INTEREST0136690635 pdf
Dec 19 2002BANK OF AMERICA, N A , AS COLLATERAL AGENTHERCULES FINANCE COMPANYRELEASE OF SECURITY INTEREST0136690635 pdf
Dec 19 2002BANK OF AMERICA, N A , AS COLLATERAL AGENTFIBERVISIONS, L L C RELEASE OF SECURITY INTEREST0136690635 pdf
Dec 19 2002BANK OF AMERICA, N A , AS COLLATERAL AGENTFIBERVISIONS INCORPORATEDRELEASE OF SECURITY INTEREST0136690635 pdf
Dec 19 2002BANK OF AMERICA, N A , AS COLLATERAL AGENTFIBERVISIONS PRODUCTS, INC RELEASE OF SECURITY INTEREST0136690635 pdf
Dec 19 2002BANK OF AMERICA, N A , AS COLLATERAL AGENTHERCULES INTERNATIONAL LIMITEDRELEASE OF SECURITY INTEREST0136690635 pdf
Dec 19 2002BANK OF AMERICA, N A , AS COLLATERAL AGENTBETZDEARBORN, INC RELEASE OF SECURITY INTEREST0136690635 pdf
Dec 19 2002BANK OF AMERICA, N A , AS COLLATERAL AGENTBETZDEARBORN EUROPE, INC RELEASE OF SECURITY INTEREST0136690635 pdf
Dec 19 2002BANK OF AMERICA, N A , AS COLLATERAL AGENTDRC LTD RELEASE OF SECURITY INTEREST0136690635 pdf
Dec 19 2002BANK OF AMERICA, N A , AS COLLATERAL AGENTBL TECHNOLOGIES, INC RELEASE OF SECURITY INTEREST0136690635 pdf
Dec 19 2002BANK OF AMERICA, N A , AS COLLATERAL AGENTBLI HOLDING CORPORATIONRELEASE OF SECURITY INTEREST0136690635 pdf
Dec 19 2002BANK OF AMERICA, N A , AS COLLATERAL AGENTHercules IncorporatedRELEASE OF SECURITY INTEREST0136690635 pdf
Date Maintenance Fee Events
Jan 12 1994M183: Payment of Maintenance Fee, 4th Year, Large Entity.
Feb 02 1994ASPN: Payor Number Assigned.
Nov 12 1997M184: Payment of Maintenance Fee, 8th Year, Large Entity.
May 14 2002REM: Maintenance Fee Reminder Mailed.
Jun 19 2002M182: 11.5 yr surcharge- late pmt w/in 6 mo, Large Entity.
Jun 19 2002M185: Payment of Maintenance Fee, 12th Year, Large Entity.


Date Maintenance Schedule
Oct 30 19934 years fee payment window open
Apr 30 19946 months grace period start (w surcharge)
Oct 30 1994patent expiry (for year 4)
Oct 30 19962 years to revive unintentionally abandoned end. (for year 4)
Oct 30 19978 years fee payment window open
Apr 30 19986 months grace period start (w surcharge)
Oct 30 1998patent expiry (for year 8)
Oct 30 20002 years to revive unintentionally abandoned end. (for year 8)
Oct 30 200112 years fee payment window open
Apr 30 20026 months grace period start (w surcharge)
Oct 30 2002patent expiry (for year 12)
Oct 30 20042 years to revive unintentionally abandoned end. (for year 12)